Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Fri, 28 Apr 17 15:54:47 +0000 Fri, 28 Apr 17 15:54:47 +0000 FDA Expands Approval of Stivarga for Liver Cancer http://www.pharmacytimes.com/product-news/fda-expands-approval-of-stivarga-for-liver-cancer http://www.pharmacytimes.com/product-news/fda-expands-approval-of-stivarga-for-liver-cancer The FDA has expanded the approved use of Stivarga (regorafenib, Bayer HealthCare Pharmaceuticals Inc.) to include the treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.&nbsp; Thu, 27 Apr 17 17:41:30 +0000 FDA Approves Treatment for Rare Form of Batten Disease http://www.pharmacytimes.com/product-news/fda-approves-treatment-for-rare-form-of-batten-disease http://www.pharmacytimes.com/product-news/fda-approves-treatment-for-rare-form-of-batten-disease The FDA has approved cerliponase alfa (Brineura, BioMarin Pharmaceutical) to slow loss of walking ability in symptomatic pediatric patients aged 3 years and older with a specific form of Batten disease Thu, 27 Apr 17 05:00:00 +0000 14 Companies Illegally Selling Cancer Drugs Receive FDA Warning Letters http://www.pharmacytimes.com/news/14-companies-illegally-selling-cancer-drugs-receive-fda-warning-letters http://www.pharmacytimes.com/news/14-companies-illegally-selling-cancer-drugs-receive-fda-warning-letters The FDA has issued 14 warning letters and 4 online advisory letters to US-based companies illegally selling more than 65 products with fraudulent claims that they cure cancer.&nbsp; Tue, 25 Apr 17 18:54:38 +0000 Pharmacist Counseling Points for Malaria Prevention http://www.pharmacytimes.com/news/pharmacist-counseling-points-for-malaria-prevention http://www.pharmacytimes.com/news/pharmacist-counseling-points-for-malaria-prevention According to the CDC, approximately 1500-2000 cases of malaria are reported each year in the United States, mostly in recent travelers.&nbsp; Tue, 25 Apr 17 17:08:12 +0000 FDA Approves Once-Monthly Dosing for Praluent Injection http://www.pharmacytimes.com/product-news/fda-approves-oncemonthly-dosing-for-praluent-injection http://www.pharmacytimes.com/product-news/fda-approves-oncemonthly-dosing-for-praluent-injection The FDA has approved Sanofi and Regeneron&rsquo;s new supplemental biologics license application for a once-monthly, 300-mg dose of Praluent (alirocumab) injection. Tue, 25 Apr 17 14:49:53 +0000 How Prepared is the United States for a Public Health Emergency? http://www.pharmacytimes.com/news/how-prepared-is-the-united-states-for-a-public-health-emergency http://www.pharmacytimes.com/news/how-prepared-is-the-united-states-for-a-public-health-emergency The Robert Wood Johnson Foundation (RWJF) released the results of the 2017 National Health Security Preparedness Index, which assessed the United States&rsquo; day-to-day preparedness in the event of a community health emergency. Tue, 25 Apr 17 13:41:16 +0000 Hospira Recalls Dextrose Injection Lot Due to Human Hair http://www.pharmacytimes.com/product-news/hospira-recalls-dextrose-injection-lot-due-to-human-hair http://www.pharmacytimes.com/product-news/hospira-recalls-dextrose-injection-lot-due-to-human-hair Hospira, a Pfizer company, has issued a nationwide recall of 1 lot of 25% Dextrose Injection, USP (Infant), pre-filled syringe to the hospital/user level, according to FDA officials.&nbsp; Sun, 23 Apr 17 13:49:32 +0000 FDA Approves Biosimilar http://www.pharmacytimes.com/news/fda-approves-biosimilar- http://www.pharmacytimes.com/news/fda-approves-biosimilar- The FDA today announced the approval of the biosimilar product infliximab-abda. Fri, 21 Apr 17 21:18:29 +0000 Recent Pharmacy Robbery Statistics http://www.pharmacytimes.com/news/recent-pharmacy-robbery-statistics http://www.pharmacytimes.com/news/recent-pharmacy-robbery-statistics The latest Pharmacy Armed Robbery statistics for 2016 have been released by the Drug Enforcement Agency (DEA). Fri, 21 Apr 17 16:57:09 +0000 FDA Updates Restrictions of Codeine and Tramadol Use in Children, Nursing Mothers http://www.pharmacytimes.com/product-news/fda-updates-restrictions-of-codeine-and-tramadol-use-in-children-nursing-mothers http://www.pharmacytimes.com/product-news/fda-updates-restrictions-of-codeine-and-tramadol-use-in-children-nursing-mothers The FDA has issued a drug safety communication regarding new restrictions for the use of codeine and tramadol medications in children and nursing mothers.&nbsp; Thu, 20 Apr 17 17:20:07 +0000 FDA Approves Stimulation Therapy Device for Episodic Cluster Headache http://www.pharmacytimes.com/product-news/fda-approves-stimulation-therapy-device-for-episodic-cluster-headache http://www.pharmacytimes.com/product-news/fda-approves-stimulation-therapy-device-for-episodic-cluster-headache The FDA has approved the first noninvasive vagus nerve stimulation device, gammaCore, for the acute treatment of pain from episodic cluster headache in adult patients, the manufacturer electroCore announced in a press release.&nbsp; Tue, 18 Apr 17 19:18:16 +0000 Report: Parents Unsure When Choosing OTC Allergy Medications for Their Children http://www.pharmacytimes.com/news/report-parents-unsure-when-choosing-otc-allergy-medications-for-their-children http://www.pharmacytimes.com/news/report-parents-unsure-when-choosing-otc-allergy-medications-for-their-children Parents often experience difficulties when selecting an allergy medicine for their child, according to responses from a new poll report.&nbsp; Tue, 18 Apr 17 14:25:01 +0000 FDA Grants Approval for Diabetic Retinopathy Treatment http://www.pharmacytimes.com/news/fda-grants-approval-for-diabetic-retinopathy-treatment http://www.pharmacytimes.com/news/fda-grants-approval-for-diabetic-retinopathy-treatment The FDA granted approval to ranibizumab injection (Lucentis) for the monthly treatment of all forms of diabetic retinopathy.<br /> &nbsp; Tue, 18 Apr 17 12:15:35 +0000 Homeopathic Teething Tablets Recalled Due to Mislabeling http://www.pharmacytimes.com/product-news/homeopathic-teething-tablets-recalled-due-to-mislabeling http://www.pharmacytimes.com/product-news/homeopathic-teething-tablets-recalled-due-to-mislabeling Standard Homeopathic Company has issued a nationwide recall of its Hyland&rsquo;s Baby Teething Tablets and Hyland&rsquo;s Baby Nighttime Teething Tablets.&nbsp; Mon, 17 Apr 17 13:22:42 +0000 7 New FDA Approvals to Know from March 2017 http://www.pharmacytimes.com/news/7-new-fda-approvals-to-know-from-march-2017 http://www.pharmacytimes.com/news/7-new-fda-approvals-to-know-from-march-2017 Learn about the new products and expanded indications approved by the FDA in March 2017. Thu, 13 Apr 17 13:00:46 +0000 Live-Attenuated Zika Vaccine Candidate Successful in Mice http://www.pharmacytimes.com/news/liveattenuated-zika-vaccine-candidate-successful-in-mice http://www.pharmacytimes.com/news/liveattenuated-zika-vaccine-candidate-successful-in-mice A developmental live-attenuated Zika vaccine showed complete protection from the virus in mice after a single vaccination dose, according to new research published in <em>Nature Medicine</em>.<sup>1</sup> Wed, 12 Apr 17 12:00:00 +0000 Medicare Advantage, Part D Programs Finalized for Next Year http://www.pharmacytimes.com/news/medicare-advantage-part-d-programs-finalized-for-next-year http://www.pharmacytimes.com/news/medicare-advantage-part-d-programs-finalized-for-next-year The final policies are similar to those proposed in February, but underwent changes that were discussed during the public comment period.&nbsp; Wed, 12 Apr 17 06:28:23 +0000 FDA Approves First Drug for Tardive Dyskinesia http://www.pharmacytimes.com/product-news/fda-approves-first-drug-for-tardive-dyskinesia http://www.pharmacytimes.com/product-news/fda-approves-first-drug-for-tardive-dyskinesia The FDA has approved valbenazine (Ingrezza, Neurocrine Biosciences Inc.) capsules, the first drug approved to treat adults with tardive dyskinesia.&nbsp; Tue, 11 Apr 17 23:00:00 +0000 Researchers Note Tigecycline-Resistant Human Pathogens in Dogs http://www.pharmacytimes.com/news/researchers-note-tigecyclineresistant-human-pathogens-in-dogs http://www.pharmacytimes.com/news/researchers-note-tigecyclineresistant-human-pathogens-in-dogs Spanish researchers have documented the first example of tigecycline-resistant bacteria adapted to living on companion animals through a study that analyzed bacteria isolated from dogs at a veterinary hospital.&nbsp; Tue, 11 Apr 17 14:27:18 +0000 Thirteen Indicted in Pill Mill and Health Care Fraud Scheme http://www.pharmacytimes.com/news/thirteen-indicted-in-pill-mill-and-health-care-fraud-scheme- http://www.pharmacytimes.com/news/thirteen-indicted-in-pill-mill-and-health-care-fraud-scheme- The indictments contain a combined 477 charges that include counts of money laundering, health care fraud, and unlawfully selling prescriptions of controlled substances.<br /> &nbsp; Mon, 10 Apr 17 16:03:44 +0000 FDA Approves 2 Hepatitis C Drugs for Use in Pediatric Patients http://www.pharmacytimes.com/product-news/fda-approves-2-hepatitis-c-drugs-for-use-in-pediatric-patients http://www.pharmacytimes.com/product-news/fda-approves-2-hepatitis-c-drugs-for-use-in-pediatric-patients The FDA approved supplemental applications for Sovaldi (sofosubuvir) and Harvoni (ledipasvir and sofosbuvir), marketed by Gilead Sciences Inc., to treat hepatitis C virus (HCV) in pediatric patients.&nbsp; Fri, 07 Apr 17 15:37:39 +0000 Physician Sentenced for Pain Clinic Pill Mill Conspiracy http://www.pharmacytimes.com/news/physician-sentenced-for-pain-clinic-pill-mill-conspiracy http://www.pharmacytimes.com/news/physician-sentenced-for-pain-clinic-pill-mill-conspiracy A former physician and owner of a pain clinic in Atlanta, Georgia, has been sentenced for his involvement in a prescription painkiller distribution conspiracy, according to a Department of Justice press release.&nbsp; Thu, 06 Apr 17 14:34:09 +0000 Study: Doxycycline for PTSD Treatment? http://www.pharmacytimes.com/news/study-doxycycline-for-ptsd-treatment http://www.pharmacytimes.com/news/study-doxycycline-for-ptsd-treatment Doxycycline disrupts the formation of negative associations in the brain that contribute to post-traumatic stress disorder (PTSD), a new study published in <em>Molecular Psychiatry</em> concluded.&nbsp; Wed, 05 Apr 17 17:05:05 +0000 CDC: Medicaid Preferred Drug List Policies May Affect Methadone Overdose Rates http://www.pharmacytimes.com/news/cdc-medicaid-preferred-drug-list-policies-may-affect-methadone-overdose-rates http://www.pharmacytimes.com/news/cdc-medicaid-preferred-drug-list-policies-may-affect-methadone-overdose-rates A study published in the CDC&rsquo;s <em>Morbidity and Mortality Weekly Report</em> aimed to determine whether a decline in methadone-related deaths was related to the Medicaid reimbursement policies designed to reduce methadone prescribing.&nbsp; Tue, 04 Apr 17 14:38:40 +0000 FDA Approves Expanded Indication of Epilepsy Drug for Migraine Prevention http://www.pharmacytimes.com/product-news/fda-approves-expanded-indication-of-epilepsy-drug-for-migraine-prevention http://www.pharmacytimes.com/product-news/fda-approves-expanded-indication-of-epilepsy-drug-for-migraine-prevention The FDA approved 2 supplemental new drug applications (sNDAs) for Upsher-Smith Laboratories&rsquo; Qudexy XR (topiramate) extended-release capsules. Tue, 04 Apr 17 12:00:00 +0000